Page last updated: 2024-08-24

ferric citrate and Cardiovascular Diseases

ferric citrate has been researched along with Cardiovascular Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bino, A; Ganz, T; Salusky, IB1
Ito, T; Iwashita, Y; Shigematsu, T1
Vaziri, ND1
Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F1

Reviews

4 review(s) available for ferric citrate and Cardiovascular Diseases

ArticleYear
Mechanism of Action and Clinical Attributes of Auryxia
    Drugs, 2019, Volume: 79, Issue:9

    Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Iron; Iron Overload; Phosphates; Renal Insufficiency, Chronic; Risk Factors; Treatment Outcome

2019
[Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Clinical calcium, 2016, Volume: 26, Issue:2

    Topics: Bone and Bones; Bone Diseases, Metabolic; Calcimimetic Agents; Calcinosis; Calcium Carbonate; Cardiovascular Diseases; Cinacalcet; Ferric Compounds; Fractures, Bone; Humans; Minerals; Parathyroidectomy; Phosphates; Phosphorus, Dietary; Renal Insufficiency, Chronic; Risk Factors; Sevelamer

2016
Safety Issues in Iron Treatment in CKD.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Anemia, Iron-Deficiency; Cardiovascular Diseases; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Disease Progression; Ferric Compounds; Hematinics; Humans; Iron Compounds; Iron Overload; Kidney Failure, Chronic; Oxidative Stress; Reactive Oxygen Species; Renal Dialysis; Renal Insufficiency, Chronic

2016
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25 Suppl 2

    Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therapy, Combination; Epoxy Compounds; Female; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Male; Multivariate Analysis; Niacinamide; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors; Sevelamer; Time Factors

2005